Funding for this research was provided by:
Received: 27 April 2018
Accepted: 31 May 2018
First Online: 3 July 2018
Duality of interest
: LJ is employed by Antaros Medical. MK, TM, G-BF and JO are employed by AstraZeneca. JWE, UR and LL have received consultancy fees for planning of this study. JWE has received research grants or honoraria from AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, Novo Nordisk and Sanofi. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.